Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Routy

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
Science (New York, N.Y.)|August 22, 2020
Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophageAurélie Fluckiger, Romain Daillère, Mohamed Sassi, et al.
Cell|June 21, 2024
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcomeLisa Derosa, Valerio Iebba, Carolina Alves Costa Silva, et al.
Nature Medicine|June 25, 2026
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profilingDéborah Suissa, Marine Fidelle, Ella Reich, et al.
Science (New York, N.Y.)|June 8, 2023
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancersMarine Fidelle, Conrad Rauber, Carolina Alves Costa Silva, et al.
Cell Death and Differentiation|July 7, 2021
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosisAnne-Gaëlle Goubet, Agathe Dubuisson, Arthur Geraud, et al.
Nature Medicine|July 9, 2021
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockadeMiles C Andrews, Connie P M Duong, Vancheswaran Gopalakrishnan, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
Science (New York, N.Y.)|August 22, 2020
Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophageAurélie Fluckiger, Romain Daillère, Mohamed Sassi, et al.
Cell|June 21, 2024
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcomeLisa Derosa, Valerio Iebba, Carolina Alves Costa Silva, et al.
Nature Medicine|June 25, 2026
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profilingDéborah Suissa, Marine Fidelle, Ella Reich, et al.
Science (New York, N.Y.)|June 8, 2023
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancersMarine Fidelle, Conrad Rauber, Carolina Alves Costa Silva, et al.
Cell Death and Differentiation|July 7, 2021
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosisAnne-Gaëlle Goubet, Agathe Dubuisson, Arthur Geraud, et al.
Nature Medicine|July 9, 2021
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockadeMiles C Andrews, Connie P M Duong, Vancheswaran Gopalakrishnan, et al.
Pageof 13